EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Acute Neurologic Decline in the ED: A Case Report on Recognizing ARIA in the Age of Anti-Amyloid Therapy

Christopher Blanton, Joel Hines, Joshua Ginsburg, Samuel Parnell

Journal of Education and Teaching in Emergency Medicine · 31.10.2026 · 11 (4)

DOI: 10.5070/m5.61894 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Education and Teaching in Emergency Medicine, online erschienen am 31.10.2026. Verfasst von Christopher Blanton und 3 weiteren Autor:innen. Beteiligte Einrichtung: UT Southwestern, Department of Emergency Medicine, Dallas, TX. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-amyloid beta (Aß) immunotherapies are an emerging treatment for Alzheimer’s disease (AD) with a rare but significant risk of amyloid-related imaging abnormalities (ARIA). This visual case report describes a patient with lecanemab-induced ARIA to familiarize emergency providers with this critical adverse effect of novel anti-amyloid therapies. An 85-year-old female receiving lecanemab infusions presented to the emergency department (ED) with abruptly worsening confusion, an unsteady gait, and new left-sided deficits, including homonymous hemianopia and hemineglect. A non-contrast head computed tomography (CT) revealed extensive right parieto-occipital vasogenic edema, prompting magnetic resonance imaging (MRI), which confirmed extensive ARIA with edema (ARIA-E) on fluid-attenuated inversion recovery (FLAIR) sequences and microhemorrhages (ARIA-H) on T2-weighted sequences. Lecanemab was discontinued, and the patient experienced partial neurologic recovery after a four-day admission. However, she was discharged with persistent functional limitations, including an inability to drive and a need for caregiver assistance. This case underscores the need for emergency physicians to maintain a high index of suspicion for ARIA in patients on anti-Aß immunotherapies who present with new neurologic symptoms. Definitive diagnosis requires MRI, and management warrants prompt neurologic consultation.

Autor:innen und Institutionen

  • UT Southwestern, Department of Emergency Medicine, Dallas, TX.

Zitieren

APA

Blanton, C., Hines, J., Ginsburg, J., & Parnell, S. (2026). Acute Neurologic Decline in the ED: A Case Report on Recognizing ARIA in the Age of Anti-Amyloid Therapy. Journal of Education and Teaching in Emergency Medicine, 11(4). https://doi.org/10.5070/m5.61894

Vancouver

Blanton C, Hines J, Ginsburg J, Parnell S. Acute Neurologic Decline in the ED: A Case Report on Recognizing ARIA in the Age of Anti-Amyloid Therapy. Journal of Education and Teaching in Emergency Medicine. 2026;11(4). doi:10.5070/m5.61894

BibTeX
@article{Blanton2026,
  author = {Blanton, Christopher and Hines, Joel and Ginsburg, Joshua and Parnell, Samuel},
  title = {Acute Neurologic Decline in the ED: A Case Report on Recognizing ARIA in the Age of Anti-Amyloid Therapy},
  journal = {Journal of Education and Teaching in Emergency Medicine},
  year = {2026},
  volume = {11},
  number = {4},
  doi = {10.5070/m5.61894}
}
Kostenlos starten →